Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 12826431

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2003 Jun 21
First author
Parmar MK

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2003 Jun 21;361(9375):2094-5. doi: 10.1016/s0140-6736(03)13726-9.
    note
    Source null
    related pmid
    12826426
    relationship
    Comment in
  2. citation
    Lancet. 2003 Oct 18;362(9392):1333; author reply 1334. doi: 10.1016/S0140-6736(03)14602-8.
    note
    Source null
    related pmid
    14575996
    relationship
    Comment in
  3. citation
    Lancet. 2003 Oct 18;362(9392):1333; author reply 1334. doi: 10.1016/S0140-6736(03)14601-6.
    note
    Source null
    related pmid
    14575997
    relationship
    Comment in
  4. citation
    Lancet. 2003 Oct 18;362(9392):1334; author reply 1334. doi: 10.1016/S0140-6736(03)14603-X.
    note
    Source null
    related pmid
    14575998
    relationship
    Comment in
  5. citation
    Nat Clin Pract Oncol. 2007 Jun;4(6):340-1. doi: 10.1038/ncponc0795.
    note
    Source null
    related pmid
    17406383
    relationship
    Comment in

Authors and identifiers

  1. name
    Parmar MK
    type
    Author
  2. name
    Ledermann JA
    type
    Author
  3. name
    Colombo N
    type
    Author
  4. name
    du Bois A
    type
    Author
  5. name
    Delaloye JF
    type
    Author
  6. name
    Kristensen GB
    type
    Author
  7. name
    Wheeler S
    type
    Author
  8. name
    Swart AM
    type
    Author
  9. name
    Qian W
    type
    Author
  10. name
    Torri V
    type
    Author
  11. name
    Floriani I
    type
    Author
  12. name
    Jayson G
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Parmar MK
    type
    Author
  2. name
    Ledermann JA
    type
    Author
  3. name
    Colombo N
    type
    Author
  4. name
    du Bois A
    type
    Author
  5. name
    Delaloye JF
    type
    Author
  6. name
    Kristensen GB
    type
    Author
  7. name
    Wheeler S
    type
    Author
  8. name
    Swart AM
    type
    Author
  9. name
    Qian W
    type
    Author
  10. name
    Torri V
    type
    Author
  11. name
    Floriani I
    type
    Author
  12. name
    Jayson G
    type
    Author
bibliography ids
  1. nci-bib-74a43bcda69d8cf986f64126
book metadata
content sha256
7213670c9465b4a799651c4fa69ba527b7b08318ad232422c4532fe8c0dc1eac
document type
citation
dois
  1. 10.1016/s0140-6736(03)13718-x
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:12826431
immutable id
pubmed:12826431@7213670c9465b4a799651c4fa69ba527b7b08318ad232422c4532fe8c0dc1eac
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9375
name
Lancet (London, England)
nlm unique id
2985213R
pages
2099-106
volume
361
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2003 Jun 21;361(9375):2094-5. doi: 10.1016/s0140-6736(03)13726-9.
    note
    Source null
    related pmid
    12826426
    relationship
    Comment in
  2. citation
    Lancet. 2003 Oct 18;362(9392):1333; author reply 1334. doi: 10.1016/S0140-6736(03)14602-8.
    note
    Source null
    related pmid
    14575996
    relationship
    Comment in
  3. citation
    Lancet. 2003 Oct 18;362(9392):1333; author reply 1334. doi: 10.1016/S0140-6736(03)14601-6.
    note
    Source null
    related pmid
    14575997
    relationship
    Comment in
  4. citation
    Lancet. 2003 Oct 18;362(9392):1334; author reply 1334. doi: 10.1016/S0140-6736(03)14603-X.
    note
    Source null
    related pmid
    14575998
    relationship
    Comment in
  5. citation
    Nat Clin Pract Oncol. 2007 Jun;4(6):340-1. doi: 10.1038/ncponc0795.
    note
    Source null
    related pmid
    17406383
    relationship
    Comment in
outcomes validated
false
pmid
12826431
provenance
batch id
2d0158fe73b50bb1a4bf
provider
NCBI PubMed ESummary
record sha256
ba0c68066d194e24c7c925e7820891598cbe4a641e7e239daa87054ddce5f87b
response sha256
d46de44782d91ef4394e88a69f82b1ee22148e8c4cf1534eb36c80479345e70e
retrieved at
2026-09-09T23:45:50.935339+00:00
publication date
display
2003 Jun 21
precision
day
year
2003
publication types
  1. Clinical Trial
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/12826431/
title
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

Preserved source evidence · Not medical advice